Roche Acquires PathAI for $750M to Bolster AI-Driven Diagnostic Capabilities
Roche to acquire digital pathology company PathAI for $750M upfront plus $300M in milestones, strengthening AI-driven diagnostic capabilities and precision medicine strategy.
RHHBYAI technologyprecision medicine






